IQVIA Company Overview


What is the Stock Ticker for IQVIA?

The stock ticker for IQVIA is IQV.

Where is the IQVIA headquarters?

IQVIA's headquarters is located in Durham, North Carolina, United States.

What Does IQVIA Do?

IQVIA is a global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. They help their clients to improve their clinical, commercial, and operational performance by providing insights and solutions that drive better outcomes. IQVIA's services include clinical trial design and management, real-world data analytics, market research, and consulting.

How Does IQVIA Make Money?

IQVIA is a global provider of information, technology solutions, and contract research services to the life sciences industry. The company operates in three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

The Technology & Analytics Solutions segment provides software and information solutions to support clinical trials, drug safety, and commercialization activities. This segment generates revenue through the sale of software licenses, subscriptions, and related services.

The Research & Development Solutions segment provides a range of services to support the drug development process, including clinical trial management, data management, and regulatory affairs. This segment generates revenue through contracts with pharmaceutical and biotechnology companies.

The Contract Sales & Medical Solutions segment provides outsourced sales and marketing services to pharmaceutical and biotechnology companies. This segment generates revenue through contracts with these companies.

Overall, IQVIA generates revenue through a combination of software and information solutions, contract research services, and outsourced sales and marketing services. The company's revenue is primarily driven by contracts with pharmaceutical and biotechnology companies, which rely on IQVIA's services to support their drug development and commercialization activities.

Who Founded IQVIA?

IQVIA was founded by Dennis Gillings and Ron Wooten in 1982.

What is the History of IQVIA?

IQVIA is a multinational company that provides information, technology, and services to the healthcare industry. The company was founded in 2016 through the merger of IMS Health and Quintiles, two leading companies in the healthcare industry.

IMS Health was founded in 1954 as Intercontinental Marketing Services and initially focused on providing market research to the pharmaceutical industry. Over the years, the company expanded its services to include data analytics, consulting, and technology solutions.

Quintiles was founded in 1982 as a clinical research organization and played a significant role in the development of many of the world's leading pharmaceutical products. The company also provided consulting and technology solutions to the healthcare industry.

The merger of IMS Health and Quintiles in 2016 created IQVIA, a company with a broad range of capabilities and expertise in the healthcare industry. Today, IQVIA serves clients in more than 100 countries and employs over 70,000 people worldwide.

What Industry is IQVIA In?

IQVIA is in the healthcare and life sciences industry.

What Are IQVIA's Competitive Advantages?

IQVIA has several competitive advantages that set it apart from its competitors. Some of these advantages include:

1. Data and Analytics: IQVIA has access to one of the largest healthcare databases in the world, which allows it to provide clients with valuable insights and analytics. This data includes information on patient demographics, treatment patterns, and outcomes, which can be used to inform clinical trial design, drug development, and commercialization strategies.

2. Global Reach: IQVIA operates in over 100 countries, giving it a global footprint that few other companies can match. This allows it to provide clients with local expertise and insights, as well as access to diverse patient populations for clinical trials.

3. Technology and Innovation: IQVIA is at the forefront of healthcare technology and innovation, with a focus on digital health, real-world evidence, and artificial intelligence. This allows it to provide clients with cutting-edge solutions that can improve patient outcomes and drive business success.

4. Industry Expertise: IQVIA has deep expertise in the healthcare industry, with a team of experienced professionals who understand the complex regulatory and market dynamics that impact drug development and commercialization. This expertise allows it to provide clients with tailored solutions that meet their specific needs and goals.

5. Integrated Solutions: IQVIA offers a range of integrated solutions that span the entire drug development and commercialization process, from clinical trial design to market access and sales. This allows clients to work with a single partner who can provide end-to-end support, streamlining the process and reducing costs.

What Are IQVIA's Competitive Threats?

Some competitive threats to IQVIA include other healthcare data and analytics companies such as Optum, IBM Watson Health, and Cerner Corporation. Additionally, there is the potential for new entrants into the market, as well as the threat of regulatory changes that could impact the company's operations. Finally, there is the risk of losing key clients to competitors or failing to keep up with technological advancements in the industry.

Who Are Some of the Competitors of IQVIA?

Some of the competitors of IQVIA include:

1. Cognizant Technology Solutions
2. Accenture
3. PAREXEL International Corporation
4. Syneos Health
5. ICON plc
6. PRA Health Sciences
7. Charles River Laboratories
8. Covance Inc.
9. QuintilesIMS
10. LabCorp.

What Are Some of IQVIA's Products and Services?

Some notable products and services from IQVIA include clinical trial management software, real-world data analytics, healthcare consulting services, and market research reports on the pharmaceutical industry. They also offer data management and integration solutions, patient recruitment and retention services, and regulatory compliance support.

Has IQVIA Acquired any Companies?

Yes, IQVIA has made several notable acquisitions, including:

1. IMS Health: In 2016, IQVIA acquired IMS Health, a leading provider of healthcare data and analytics, for $7.4 billion.

2. DrugDev: In 2017, IQVIA acquired DrugDev, a technology company that provides clinical trial management solutions, for an undisclosed amount.

3. Linguamatics: In 2019, IQVIA acquired Linguamatics, a natural language processing (NLP) technology company, for an undisclosed amount.

4. Aetion: In 2021, IQVIA acquired Aetion, a healthcare analytics company, for $1.3 billion.

More Companies